Publication:
Development and validation of an HPLC method for determination of nateglinide in drug substances

dc.contributor.authorsHacioglu, Aylin; Citlak, Aysin; Karakus, Sevgi
dc.date.accessioned2022-03-13T12:48:19Z
dc.date.accessioned2026-01-11T07:24:46Z
dc.date.available2022-03-13T12:48:19Z
dc.date.issued2015
dc.description.abstractThe scope of this study was the development and validation of a reliable, rapid, simple, sensitive, precise reversed-phase high performance liquid chromatography (RP-HPLC) method for the determination of nateglinide in drug substances. The method was developed on ACE C-18 analytical column (150 x 4.6 mm i.d., particle size 5.0 mu m) using a mobile phase of acetonitrile and 0.05% trifluoroacetic acid (25: 25, v/v). The eluent was monitored with UV detection at 210 nm at a flow rate of 1.5 mL/min. Calibration curve was linear between the concentration range of 0.2846-1.0125 mg/mL. The retention time of Nateglinide was 7.07 min and the correlation coefficient (r) of the regression equation for the Nateglinide was greater than 0.99 in all cases.
dc.identifier.doidoiWOS:000361222900003
dc.identifier.issn1309-0801
dc.identifier.urihttps://hdl.handle.net/11424/238191
dc.identifier.wosWOS:000361222900003
dc.language.isoeng
dc.publisherMARMARA UNIV, FAC PHARMACY
dc.relation.ispartofMARMARA PHARMACEUTICAL JOURNAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNateglinide
dc.subjectHPLC assay
dc.subjectmethod validation
dc.subjectLIQUID-CHROMATOGRAPHY
dc.subjectRABBIT PLASMA
dc.titleDevelopment and validation of an HPLC method for determination of nateglinide in drug substances
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage108
oaire.citation.issue2
oaire.citation.startPage103
oaire.citation.titleMARMARA PHARMACEUTICAL JOURNAL
oaire.citation.volume19

Files